Comparing prescription routes for melasma calls for a comparison of real product roles, rather than a league table of claims. The other selections show different formats or access routes, with explicit labels when they are alternatives to the ingredient named in this site's address.

For this comparison, the useful starting point is the labeled Tri-Luma medicine and the individually prescribed compounded formulas offered by CoreAge, Musely and Agency. The cards keep the source, category and price question next to each product. They do not award an invented clinical score or imply that a retail cosmetic, a compounded prescription and a labeled medicine were tested against each other.

02

Prescription hydroquinone combination

Tri-Luma Cream

A sourced look at Tri-Luma Cream: formulation, category, practical tradeoffs and current price information.

Price snapshot
Confirm current price and size on the official page
Source checked
October 1, 2026
03

Prescription dark spot treatment

Musely The Spot Cream

A sourced look at Musely The Spot Cream: formulation, category, practical tradeoffs and current price information.

Price snapshot
Confirm current price and size on the official page
Source checked
October 1, 2026
04

Prescription dark spot treatment

Agency Dark Spot Rx

A sourced look at Agency Dark Spot Rx: formulation, category, practical tradeoffs and current price information.

Price snapshot
Confirm current price and size on the official page
Source checked
October 1, 2026

Read the cards by category

Melasma, post-inflammatory marks and sun-related spots are not one diagnosis. A dermatologist may need to examine a lesion before any lightening product is appropriate. Prescription hydroquinone and non-hydroquinone cosmetic brighteners have different oversight and evidence. Results also depend on sun protection and control of the condition causing pigment. A high ingredient percentage or a rapid-fade promise cannot replace that assessment. The selected products are therefore described by their actual role. Follow the review before making a purchase decision, because a short comparison card cannot describe every ingredient, indication, warning or renewal term. In particular, a nonprescription alternative is included for context and does not establish that its brand supplies the prescription ingredient.

Our source process looks for an official manufacturer or provider page first, then an authoritative clinical or regulatory source for the broader question. We record the check date and separate those two kinds of evidence. A live product listing establishes what is advertised; it does not independently establish a treatment result or prove the dispensing details of an individual order.

The routine and the budget

Compare the total over a common period. A 30-day subscription, a 90-day supply and a retail bottle will otherwise appear artificially cheap or expensive beside one another. Include consultation, delivery, refills and supporting skincare where relevant. A starting price is a provider claim and may not describe your final prescribed treatment or chosen product size.

Hydroquinone needs a clinician-directed treatment window and monitoring. Unusual darkening or a blue-gray change should be reported promptly. Do not self-treat a spot that is new, changing, bleeding or otherwise concerning. Irritation from several brightening ingredients can itself complicate uneven pigmentation. Broad-spectrum sunscreen and, when recommended for melasma, visible-light protection belong in the plan rather than being optional add-ons. A product that is difficult to tolerate or does not fit the diagnosis is not improved by a lower headline price. Questions about irritation and supervision belong beside formulation and cost, particularly for readers who already have a complicated skincare routine.

How to use this comparison

Open two individual reviews in the same category, read their formulation sections and check the official source links. Then use the related guide to clarify the ingredient or format question. We describe the uncertainties rather than hide them behind numerical ratings. If the concern is persistent, new or changing, a qualified clinician can help identify whether any of these routes is relevant.

Read the linked CoreAge Rx Spot On review for the exact current provider-page facts and the ingredient evidence questions. A short card cannot settle formulation, eligibility or treatment suitability. Keep the current official label and your particular concern together when deciding what to discuss with a qualified clinician.

Sources and verification

Official pages establish product facts and provider claims. Clinical and regulatory sources answer separate evidence questions. Checked October 1, 2026. No medical reviewer is credited for this article.